Astria Therapeutics, Inc. (ATXS) Misses Q1 EPS by 13c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
• SK Hynix (SKHY) call put ratio 1.4 calls to 1 put as share price up 3.8%
• Derya Arms Signs Collaboration Agreement with Olympic Medalist Yusuf Dikec